15 Countries with Most Breast Implants in the World

15 Countries with Most Breast Implants in the World

Trade ESTA on Coinbase

In this article, we will be taking a look at the 15 countries with the most breast implants in the world. If you do not want to learn about the global breast implants market, head straight to the 5 Countries with Most Breast Implants in the World.

In recent years, the prevalence of breast augmentation surgeries has surged globally, sparking curiosity about the countries leading this trend. From bustling metropolises to serene coastal towns, the quest for enhanced aesthetics has become increasingly prevalent. This exploration delves into the nations where breast implants are most popular, shedding light on cultural perceptions, medical advancements, and societal influences driving this phenomenon. 

Global Breast Implants Market: Growth, Trends, and Projections 

The global breast implant market is experiencing significant growth, projected to increase from USD 2.31 billion in 2022 to USD 5.34 billion by 2030, with a compound annual growth rate (CAGR) of around 7.3% to 7.7%. Key factors driving this growth include

  • the rising number of breast augmentation procedures,

  • increasing incidence of breast cancer and

  • technological advancements in the industry. 

Market segmentation reveals distinct product types, shapes, applications, and end-user trends. Silicone implants hold the largest market share due to their natural look and feel, while round and anatomical shapes cater to diverse aesthetic preferences. The market encompasses reconstructive and cosmetic surgeries, with hospitals dominating the end-user segment, particularly in North America. 

Several prominent companies, including Mentor Worldwide LLC, Establishment Labs Holdings Inc. (NASDAQ: ESTA), Sientra, Inc. (NASDAQ:SIEN), and GC Aesthetics, are critical players in this market, driving innovation and competition. 

Sientra, Inc. (NASDAQ:SIEN), known for its silicone gel breast implants, markets its products through board-certified plastic surgeons for quality assurance. Despite recent efforts to expand into the Japanese market with OPUS breast implants, the company filed for bankruptcy in February 2024 due to financial difficulties, despite strong demand during the COVID-19 pandemic. Sientra, Inc. (NASDAQ:SIEN) has made significant advancements in aesthetics and plastic surgery, introducing FDA-approved breast implants with low complication rates and a natural feel. These innovations highlight the company's commitment to delivering technologically advanced products supported by robust clinical trials. 

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company specializing in women's health and wellness, particularly breast aesthetics and reconstruction. Their Motiva devices have seen widespread adoption, with over three million units in the market since 2010. The company offers a portfolio of Femtech solutions, including the Motiva Flora tissue expander and Mia Femtech for minimally invasive breast procedures. In 2024 Q1, Establishment Labs Holdings Inc. (NASDAQ:ESTA) launched Motiva Implants in China, expanding its market reach.